This course includes the recording of a live Instructional Course from the 2026 AOSSM Annual Meeting.
Please Note: The Q&A QR code in the Recording is currently inactive. Any questions submitted through it will not be monitored or answered.
IC 11-2026-Managing and Avoiding Complications during Patellar Stabilization Surgery
Course Description:
MPFL reconstruction continues to become increasingly popular in the treatment of patellar instability. Reported complication rates are up to 25%, of which almost half have been due to technical error. We review the common complications encountered during and after MPFL reconstruction, TTO, and other patellofemoral procedures. We discuss how to assess, address, and prevent such problems with surgical technique pearls. Cases demonstrating examples will be presented to highlight each principle.
Learning Objectives:
By the end of this course, participants should be able to:
- At the conclusion of this session, participants will be able to apply evidence-based surgical techniques and complication avoidance strategies during MPFL reconstruction and associated patellofemoral procedures to optimize patient outcomes and reduce technical errors.
Faculty:
- Miho Tanaka, MD, PhD
- Seth L. Sherman, MD
- Sabrina M. Strickland, MD
- Adam Yanke, MD, PhD
ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
|
|
ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.
AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credit™ participants must complete the activity and online evaluation. No hard copy submissions will be accepted.
American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP# P460) is approved by the Board of Certification, Inc. to provide continuing education to Athletic Trainers. This program is eligible for a maximum of 1 Category A CEUs. ATs should claim only those hours actually spent in the educational program.
|
| |
Miho J. Tanaka, MD PhD
Arthrex Inc: Consultant (Ongoing)|Depuy Synthes: Consultant (Ongoing)|NIH/NIAMS: Researcher (Ongoing)| Vericel: Consultant (Ongoing)
Seth Sherman, MD
Allosource: Speaker (Ongoing)|Arcuro Medical: Consultant (Ongoing)|Arcuro Medical: Paid Advisor (Ongoing)|Arthrex: Consultant (Ongoing)|ConMed: Royalties (Ongoing)|DJO: Royalties (Ongoing)|Epicrispr BioTech: Own stock options in a privately held ineligible company (Ongoing)|Icarus: Own stock options in a privately held ineligible company (Ongoing)|JRF Ortho: Speaker(Ongoing)|Kinamed: Speaker (Ongoing)|Kyniska Robotics: Consultant (Ongoing)|Kyniska Robotics: Own stock options in a privately held ineligible company (Ongoing)|Kyniska Robotics: Paid Advisor (Ongoing)|LifeNet Health: Consultant (Ongoing)|MIACH: Speaker (Ongoing)|MoxImed: Consultant (Ongoing)|MoxImed: Own stock options in a privately held ineligible company (Ongoing)|MoxImed: Paid Advisor (Ongoing)|Octane Biotherapeutics: Speaker (Ongoing)|Organogenesis: Speaker (Ongoing)|Ossio: Speaker (Ongoing)|Reparel: Consultant (Ongoing)|Reparel: Own stock options in a privately held ineligible company (Ongoing)|Reparel: Paid Advisor (Ongoing)|Sarcio Inc: Consultant (Ongoing)|Sarcio Inc: Own stock options in a privately held ineligible company (Ongoing)|Sarcio Inc: Paid Advisor (Ongoing)|Smith & Nephew: Speaker (Ongoing)|Sparta Biomedical: Consultant (Ongoing)|Sparta Biomedical: Paid Advisor (Ongoing)|Sparta-Bioenthesis: Own stock options in a privately held ineligible company (Ongoing)|Vericel: Consultant (Ongoing)|Vivorte: Consultant (Ongoing)|Vivorte: Own stock options in a privately held ineligible company (Ongoing)|Vivorte: Paid Advisor (Ongoing)
Sabrina Strickland, MD
Bioventus LLC: Consultant (Ongoing)|Depuy Synthes: Speaker (Ongoing)|MoxImed: Consultant (Ongoing)|MoxImed: Own stock options in a privately held ineligible company (Ongoing)|MoxImed: Researcher (Ongoing)|Pacira: Speaker (Ongoing)|Smith & Nephew: Consultant (Ongoing)|Smith & Nephew: Researcher (Ongoing)|Smith & Nephew: Speaker (Ongoing)|Stryker: Own stock or stock options in a publicly traded ineligible company (Ongoing)
Adam Yanke, MD
Icarus: Own stock options in a privately held ineligible company (Ongoing)|Patient IQ: Consultant (Ongoing)|Patient IQ: Own stock options in a privately held ineligible company (Ongoing)|Sparta Biomedical: Consultant (Ongoing)|Sparta Biomedical: Own stock options in a privately held ineligible company (Ongoing)|Stryker: Consultant (Ongoing)|Stryker: Speaker (Ongoing)
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.
ORIGINAL RELEASE DATE: 8/1/2026
EXPIRATION DATE: 7/31/2029